MARLBOROUGH, Massachusetts, Jan. 9, 2018 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) today announced it has obtained a CE Mark in Europe for the Brevera ® breast biopsy system with CorLumina ® ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Stereotactic breast biopsy needles have recently been placed on the medical device shortage list by FDA. The shortage could negatively impact Hologic, a company ranked 29th on MD+DI ’s Top 100 Medical ...
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, business, financing, regulation, science, ...
Indian companies posted a surprise earnings beat for the three months ended March, as domestic activity hummed along boosted by consumption tax cuts and easy monetary policy, but the Iran war-led ...
Hologic, Inc. HOLX recently announced the addition of improved features to its Brevera Breast Biopsy System with CorLumina Imaging Technology. Notably, the system was launched in 2017 and has been ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results